Epidemiologic surveillance system for drug-resistant tuberculosis in the Republic of Tajikistan: problems and ways of its improvement
https://doi.org/10.52888/0514-2515-2023-358-3-92-97
Abstract
Objective. Development of recommendations for improving the system of epidemiological surveillance of drug-resistant tuberculosis.
Material and methods. The surveillance system for drug-resistant tuberculosis in Dushanbe and the Rudaki district was evaluated, following the guidelines provided by the US Centers for Disease Control and Prevention (CDC).
Results. The tuberculosis (TB) surveillance framework is multifaceted with multiple reporting tiers. The reporting forms provided by the government do not provide information on the indicators needed to track the spread of multidrug-resistant TB. An evaluation of timeliness revealed that appropriate treatment commenced promptly in 52% of cases (42 out of 80): 54% (29 out of 54 cases) in Dushanbe and 50% (13 out of 26) in the Rudaki district. Delays were associated with multiple drug resistance in comparison to other types of drug resistance (OR-4.3; 95% CI 1.7-11.1), outpatient in contrast to inpatient treatment (OR-5.3; 95% CI 1.1-27.0).
Conclusion. The epidemiological surveillance system for TB with drug-resistant strains in both regions achieves its intended goals and objectives. However, the system’s flexibility, timeliness, and acceptability require further refinement.
About the Authors
R. N. Sharifov
Kazakh National Medical University named after S.D. Asfendiyarov;
Disinfection Center of Dushanbe City;
Central Asia Region Field Epidemiology Training Program
Tajikistan
Tajikistan
Sharifov Radjabali Nuralievich master student of the Department of Epidemiology with the course of HIV infection, Kazakh National Medical University named S.D. Asfendiyarov, Almata, Kazakhstan; Deputy head Physician of State Institution “City Disinfection Station”, Dushanbe, Tajikistan
Z. H. Tilloeva
Disinfection Center of Dushanbe City
Tajikistan
Tajikistan
D. A. Nabirova
Central Asia Region Field Epidemiology Training Program;
U.S. Centers for Disease Control and Prevention, Central Asia Regional Office
Kazakhstan
Kazakhstan
S. M. Zikriyarova
Kazakh National Medical University named after S.D. Asfendiyarov
Kazakhstan
Kazakhstan
N. J. Jafarov
Ministry of Health and Social Protection of the Population
Tajikistan
Tajikistan
S. J. Yusufi
Ministry of Health and Social Protection of the Population
Tajikistan
Tajikistan
References
1. Natsionalnaya programma zashchity naseleniya ot tuberkuleza v Respublike Tadzhikistan na 20212025 gody (Postanovlenie Pravitelstva RT № 49 ot 27.02.2021) [National Program for the Protection of the Population from Tuberculosis in the Republic of Tajikistan for 2021-2025 (Decree of the Government of the Republic of Tajikistan No. 49 dated February 27, 2021)]. Dushanbe, 2021. Available at: http://www.adlia. tj/show_doc.fwx?rgn=138960
2. Sidzhotkhonov A.A., Tilloeva Z.Kh., Dzhafarov N.Dzh. Epidemiologicheskiy nadzor za tuberkulezom v g. Dushanbe: puti sovershenstvovaniya [Tuberculosis surveillance in Dushanbe: a way forward to strengthening]. Tuberkulyoz i bolezni lyogkikh Tuberculosis and Lung Diseases, 2022, Vol. 100, No. 3, pp. 33-38.
3. Bourgeois A.C. Descriptive review of tuberculosis surveillance systems across the circumpolar regions [Descriptive review of tuberculosis surveillance systems across the circumpolar regions]. International Journal of Circumpolar Health, 2016, No. 75.
4. Drug-resistant TB could become the dominant form in Eastern Europe | UN News. Available at: https://news.un.org/ru/story/2019/03/1351751 (accessed 16.06.2022)
5. MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports, 2013, No. 13 (50), pp. 1–35.
6. Fofana B. Tuberculosis Surveillance Data Analysis, Volta Region, Ghana. Acta Scientific Medical Sciences, 2019, No. 4 (3), pp. 4–9.
7. German R.R. Updated guidelines for evaluating public health surveillance systems: recommendations from the Guidelines Working Group. MMWR. Recommendations and reports: Morbidity and mortality weekly report. Recommendations and reports, 2001, No. 13 (50), pp. 1–7.
8. Global tuberculosis report 2020. Available at: https://www.who.int/publications/i/item/9789240013131
9. Mohammed N.T. An evaluation of tuberculosis surveillance system in a health district in Ghana. International Journal of Community Medicine and Public Health, 2020, No. 3 (7), pp. 806.
10. Mohr-Holland E. Diagnosis patterns for rifampicin-resistant TB after onset of COVID-19. The international journal of tuberculosis and lung disease: the official journal of the International Union against Tuberculosis and Lung Disease, 2021, No. 9 (25), pp. 772–775.
11. Nishikiori F. Using tuberculosis surveillance data for informed programmatic decision-making. West Pacific Surveill Response Journal, 2013, No. 4 (1), pp. 1–3.
12. Updated Guidelines for Evaluating Public Health Surveillance Systems. Available at: https://www.cdc.gov/mmwr/preview/mmwrhtml/rr5013a1.htm
13. World Health Organization. Definitions and reporting framework for tuberculosis – 2013 revision. 2013.
14. World Health Organization Global tuberkulosis report. Global tuberkulosis report Publ., 2021.
Review
For citations:
Sharifov R.N., Tilloeva Z.H., Nabirova D.A., Zikriyarova S.M., Jafarov N.J., Yusufi S.J. Epidemiologic surveillance system for drug-resistant tuberculosis in the Republic of Tajikistan: problems and ways of its improvement. Health care of Tajikistan. 2023;(3):92-97. (In Russ.) https://doi.org/10.52888/0514-2515-2023-358-3-92-97
Views:
345
Email this article 